Publication: Kontrazeption bei Frauen mit Migräne
Kontrazeption bei Frauen mit Migräne
Date
Date
Date
Citations
Merki-Feld, G. S. (2013). Kontrazeption bei Frauen mit Migräne. Gynäkologische Endokrinologie, 11(3), 184–187. https://doi.org/10.1007/s10304-012-0535-1
Abstract
Abstract
Abstract
Background Migraine is a complex, disabling neurological condition characterized by recurrent episodes of headache. It affects up to 15 % of the adult population, whereby women of reproductive age are more frequently affected than men. Estrogens have been shown to play a pivotal role in migraine pathophysiology. Migraineurs are at increased for cerebral stroke and migraine is associated with an elevated risk for cardiovascular events. This risk has been shown to be especially high in migraine with aura. Contraception should not expose
Metrics
Citations
Additional indexing
Creators (Authors)
- Merki-Feld, G S
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
In collections
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Metrics
Citations
Citations
Merki-Feld, G. S. (2013). Kontrazeption bei Frauen mit Migräne. Gynäkologische Endokrinologie, 11(3), 184–187. https://doi.org/10.1007/s10304-012-0535-1
